Contact this trialFirst, we need to learn more about you.
Wnt Pathway Inhibitor
JNJ-64251330 for Adenomatous Polyposis
Recruiting1 awardPhase 1
Houston, Texas
This trial tests a pill called JNJ-64251330 to reduce gut inflammation in people with Familial Adenomatous Polyposis (FAP). The drug works by blocking proteins that cause inflammation, aiming to lower the number of colon polyps. JNJ-64251330 is related to another drug that has shown effectiveness in reducing inflammation in a rat model of colitis.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service